2016
DOI: 10.1002/pon.4127
|View full text |Cite
|
Sign up to set email alerts
|

The European organization for research and treatment of cancer — satisfaction with cancer care questionnaire: revision and extended application development

Abstract: Patient satisfaction is now recognized as an important indicator of care quality. It is also related to treatment adherence [1] and clinical outcomes [2], and facilitates monitoring initiatives for care improvement over time [3].With medical advances in oncology, new modalities of cancer care delivery have been implemented. For example, personalized and targeted therapies are increasingly being administered for extended periods of time in the outpatient setting. In addition to information about potential side … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 11 publications
0
4
0
1
Order By: Relevance
“…There are two projects that should be mentioned in this context. First, the EORTC is currently developing and testing the PATSAT-33, a cancer-care specific PREM that will not only cover in-hospital patients, but also aspects of PC in out-patient settings as well as the transitional period [ 47 ]. A phase IV validation study in several European countries is underway including German-speaking countries.…”
Section: Discussionmentioning
confidence: 99%
“…There are two projects that should be mentioned in this context. First, the EORTC is currently developing and testing the PATSAT-33, a cancer-care specific PREM that will not only cover in-hospital patients, but also aspects of PC in out-patient settings as well as the transitional period [ 47 ]. A phase IV validation study in several European countries is underway including German-speaking countries.…”
Section: Discussionmentioning
confidence: 99%
“…More research is needed in this field. There are two projects that should be mentioned in this context. First, the EORTC is currently developing and testing the PATSAT-33, a cancer-care specific PREM that will not only cover in-hospital patients, but also aspects of PC in out-patient settings as well as the transitional period [47]. A phase IV validation study in several European countries is underway including German-speaking countries.…”
Section: Discussionmentioning
confidence: 99%
“…This study therefore involved a large panel of cancer centres from different geographical regions (Northern, Eastern, Southern Europe and Anglo‐Saxon Countries ‐ as well as Asia and South America). The earlier phases of developing these measures also included patients, professionals and a group of experts from a variety of geographical areas (Brédart et al., ). Special attention was given to the wording of items to ensure that the same concepts were understood similarly in different countries (Kuliś et al., ).…”
Section: Discussionmentioning
confidence: 99%
“…We have previously reported on the initial steps (EORTC questionnaire developmental phases I and II (Johnson et al., )) taken to generate a preliminary satisfaction with cancer care core questionnaire suitable for both the in‐ and outpatient care settings and a complementary cancer outpatient satisfaction with care module addressing aspects specifically important to the outpatient setting only (Brédart et al., ).…”
Section: Introductionmentioning
confidence: 99%